Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and pH independent polymers: preparation and in vitro/in vivo characterization

References

• Abbaspour MR, Sadeghi F, Garekani HA. (2005). Preparation and characterization of ibuprofen pellets based on Eudragit RS PO and RL PO or their combination. Int J Pharm 303:88–94.
   PubMed Web of Science ®Google Scholar
• Asami M, Shigeta A, Tanaka Y. (1996). Disposition of CS-670, a novel nonsteroidal anit-inflammatory drug, and its metabolites in healthy human volunteers. Chirality 8:207–13.
   PubMed Web of Science ®Google Scholar
• Baghel S, Cathcart H, O'Reilly NJ. (2016). Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci 105:2527–44.
   PubMed Web of Science ®Google Scholar
• Bodmeier R, Guo X, Sarabia RE, et al. (1996). The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D. Pharm Res 13:52–6.
   PubMed Web of Science ®Google Scholar
• Boyapally H, Nukala RK, Douroumis D. (2009). Development and release mechanism of diltiazem HCl prolonged release matrix tablets. Drug Deliv 16:67–74.
   PubMed Web of Science ®Google Scholar
• Chime S, Onunkwo G, Onyishi I. (2013). Kinetics and mechanisms of drug release from swellable and non swellable matrices: a review. Res J Pharm Biol Chem Sci 4:97–103.
   Google Scholar
• Colombo P, Bettini R, Santi P, et al. (2000). Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today 3:198–204.
   PubMedGoogle Scholar
• Costa P, Lobo JMS. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123–33.
   PubMed Web of Science ®Google Scholar
• Gupta P, Kumar M, Sachan N. (2015). An overview on polymethacrylate polymers in gastroretentive dosage forms. Pharmsci 2:31–42.
   Google Scholar
• Haan PD, Lerk CF. (1984). Oral controlled release dosage forms. A review. Pharm Weekbl Sci 6:57–67.
   PubMedGoogle Scholar
• Higuchi T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–9.
   PubMed Web of Science ®Google Scholar
• Hixson A, Crowell J. (1931). Dependence of reaction velocity upon surface and agitation. Ind Eng Chem 23:1160–8.
   Google Scholar
• Holmström SC, Patil AJ, Butler M, et al. (2007). Influence of polymer co-intercalation on guest release from aminopropyl-functionalized magnesium phyllosilicate mesolamellar nanocomposites. J Mater Chem 17:3894–900.
   Web of Science ®Google Scholar
• Jantratid E, Janssen N, Reppas C, et al. (2008). Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res 25:1663–76.
   PubMed Web of Science ®Google Scholar
• Khodaverdi E, Javan M, Tabassi SAS, et al. (2017). Sustained drug delivery system for insulin using supramolecular hydrogels composed of tri-block copolymers. J Pharm Invest 47:263–73.
   Google Scholar
• Kim S, Gupta B, Moon C, et al. (2016). Employing an optimized spray-drying process to produce ezetimibe tablets with an improved dissolution profile. J Pharm Invest 46:583–92.
   Google Scholar
• Klein S. (2010). The use of biorelevant dissolution media to forecast the in vivo performance of a drug. aaps J 12:397–406.
   PubMed Web of Science ®Google Scholar
• Knop K. (1996). Influence of buffer solution composition on drug release from pellets coated with neutral and quaternary acrylic polymers and on swelling of free polymer films. Eur J Pharm Sci 4:293–300.
   Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35.
   Web of Science ®Google Scholar
• Marques MR, Loebenberg R, Almukainzi M. (2011). Simulated biological fluids with possible application in dissolution testing. Dissolution Technol 18:15–28.
   Web of Science ®Google Scholar
• Matsuki S, Sugimoto M, Koboyashi M, et al. (1993). Phase I study of new non-steroidal antiinflammatory drug, CS-670. Ensho 13:195–212.
   Google Scholar
• Paradkar A, Ambike AA, Jadhav BK, et al. (2004). Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int J Pharm 271:281–6.
   PubMed Web of Science ®Google Scholar
• Patil H, Tiwari RV, Upadhye SB, et al. (2015). Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process. Int J Pharm 496:33–41.
   PubMed Web of Science ®Google Scholar
• Pawar PK, Gautam C. (2016). Design, optimization and evaluation of mesalamine matrix tablet for colon drug delivery system. J Pharm Invest 46:67–78.
   Google Scholar
• Pignatello R, Bucolo C, Spedalieri G, et al. (2002). Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials 23:3247–55.
   PubMed Web of Science ®Google Scholar
• Prasad D, Chauhan H, Atef E. (2014). Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects. J Pharm Sci 103:3511–23.
   PubMed Web of Science ®Google Scholar
• Rawat M, Saraf S, Saraf S. (2007). Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres. AAPS PharmSciTech 8:289–97.
   Web of Science ®Google Scholar
• Reza MS, Quadir MA, Haider SS. (2002). Development of theophylline sustained release dosage form based on kollidon SR. Pak J Pharm Sci 15:63–70.
   PubMed Web of Science ®Google Scholar
• Ryu JH, Kim JI, Kim HS, et al. (2017). Pharmacokinetic interactions between pelubiprofen and eperisone hydrochloride: a randomized, open-label, crossover study of healthy korean men. Clin Ther 39:138–49.
   PubMed Web of Science ®Google Scholar
• Shin JS, Baek SR, Sohn SI, et al. (2011). Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF-κB inactivation. J Cell Biochem 112:3594–603.
   PubMed Web of Science ®Google Scholar
• Son G-H, Lee B-J, Cho C-W. (2017). Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles. J Pharm Invest 47:287–96.
   Google Scholar
• Song SH, Chae BR, Sohn SI, et al. (2016). Formulation of controlled-release pelubiprofen tablet using Kollidon(®) SR. Int J Pharm 511:864–75.
   PubMed Web of Science ®Google Scholar
• Takasaki W, Asami M, Muramatsu S, et al. (1993). Stereoselective determination of the active metabolites of a new anti-inflammatory agent (CS-670) in human and rat plasma using antibody-mediated extraction and high-performance liquid chromatography. J Chromatogr B 613:67–77.
   Web of Science ®Google Scholar
• Tran PH, Tran HT, Lee BJ. (2008). Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. J Control Release 129:59–65.
   PubMed Web of Science ®Google Scholar
• Vasavid P, Chaiwatanarat T, Pusuwan P, et al. (2014). Normal solid gastric emptying values measured by scintigraphy using Asian-style Meal:A Multicenter Study in Healthy Volunteers. J Neurogastroenterol Motil 20:371–8.
   PubMed Web of Science ®Google Scholar
• Wadher KJ, Kakde RB, Umekar MJ. (2011). Formulation and evaluation of sustained release matrix tablets of metformin hydrochloride using pH dependent and pH independent methacrylate polymers. Br J Pharm Res 1:29–45.
   Google Scholar
• Wagner JO. (1983). The Wagner‐Nelson method applied to a multicompartment model with zero order input. Biopharm Drug Dispos 4:359–73.
   PubMed Web of Science ®Google Scholar
• Wagner KG, Mcginity JW. (2002). Influence of chloride ion exchange on the permeability and drug release of Eudragit RS 30 D films. J Control Release 82:385–97.
   PubMed Web of Science ®Google Scholar
• Wulff R, Leopold CS. (2014). Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release. Int J Pharm 476:78–87.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Fukunishi A, Higashino H, et al. (2017). Design of supersaturable formulation of telmisartan with pH modifier: in vitro study on dissolution and precipitation. J Pharm Invest 47:163–71.
   Google Scholar
• Yang L, Choi SK, Shin HJ, et al. (2013). 3-aminopropyl functionalized magnesium phyllosilicate as an organoclay based drug carrier for improving the bioavailability of flurbiprofen. Int J Nanomedicine 8:4147–55.
   PubMed Web of Science ®Google Scholar
• Yang L, Lee YC, Kim MI, et al. (2014a). Biodistribution and clearance of aminoclay nanoparticles: implication for in vivo applicability as a tailor-made drug delivery carrier. J Mater Chem B 2:7567–74.
   PubMed Web of Science ®Google Scholar
• Yang L, Shao Y, Han HK. (2014b). Improved pH-dependent drug release and oral exposure of telmisartan, a poorly soluble drug through the formation of drug-aminoclay complex. Int J Pharm 471:258–63.
   PubMed Web of Science ®Google Scholar
• Yang L, Shao Y, Han HK. (2016). Aminoclay-lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption. Int J Nanomedicine 11:1067–76.
   PubMed Web of Science ®Google Scholar
• Ziaee A, Albadarin AB, Padrela L, et al. (2017). Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters. Eur J Pharm Biopharm 120:43–51.
   PubMed Web of Science ®Google Scholar